mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.1 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.068 |
0.1 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
Imatinib |
FIMM |
pan-cancer |
AAC |
-0.26 |
0.1 |